Sun Pharma’s arm gets USFDA nod for generic dexmedetomidine hydrochloride injection

27 Dec 2011 Evaluate

Sun Pharmaceutical Industries - US arm - Caraco Pharmaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for its generic dexmedetomidine hydrochloride injection. Dexmedetomidine is a sedative and anesthetic medication, and provides sedation without causing respiratory depression.

The tentative approval is for 100 microgram/ml strength of the injection marketed as Precedex by Hospira Inc in the US.

Recently, Sun Pharmaceutical Industries’ subsidiary had been granted an approval from USFDA for its abbreviated new drug application to market a generic version of Ultram ER, Tramadol hydrochloride extended release tablets.

Sun Pharmaceutical Industries manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1797.80 20.15 (1.13%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.